 Biocept Inc NASDAQ:BIOC has announced the publication of a study showing that the addition of Switch-Blocker technology to common PCR-based liquid biopsy assays significantly increased sensitivity in detecting rare cancer mutations. The abstract was published in the November 2021 issue of the Journal of Molecular Diagnostics. 